Jump to the Navigation Menu
Login to My AlzForum
Jump to the Search form

Papers

269303 Results

Sort By:

Publication Date
Journal Title
First Author
Most Commented

Go to another page:

29
30
31
32
33
... 17954

Send results to Selected: 0 Clear selection

Zhang DQ, Yang X, Niu HB, Sun XC, Cao DN, Li A, Yue JH, Li XL, Zhang QH. Visualization Analysis of Tau Protein in the Brain of Alzheimer's Disease: A Scoping Literature Review. Curr Alzheimer Res. 2025 Feb 3; Epub 2025 Feb 3 PubMed.

Dong N, Xie Z, Wei A, Yang Y, Deng Y, Cheng X, Wang B, Chen Y, Gu Y, Yao J, Qin Y, Zheng C, Zhang X, Zhang Y, Kang X, Chen G, Qu Q, Wang C, Xu H. Compensatory synaptotagmin-11 expression conceals parkinson's disease-like phenotypes in parkin knockout mice. Cell Commun Signal. 2025 Feb 3;23(1):61. PubMed.

Warmenhoven N, Salvadó G, Janelidze S, Mattsson-Carlgren N, Bali D, Orduña Dolado A, Kolb H, Triana-Baltzer G, Barthélemy NR, Schindler SE, Aschenbrenner AJ, Raji CA, Benzinger TL, Morris JC, Ibanez L, Timsina J, Cruchaga C, Bateman RJ, Ashton N, Arslan B, Zetterberg H, Blennow K, Pichet Binette A, Hansson O. A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests. Brain. 2025 Feb 3;148(2):416-431. PubMed.

Toniolo S. Which plasma pTau217 assay should I use in clinical practice? Pandora's box demystified. Brain. 2025 Feb 3;148(2):354-356. PubMed.

Pilotto A, Quaresima V, Trasciatti C, Tolassi C, Bertoli D, Mordenti C, Galli A, Rizzardi A, Caratozzolo S, Zancanaro A, Contador J, Hansson O, Palmqvist S, De Santis G, Zetterberg H, Blennow K, Brugnoni D, Suárez-Calvet M, Ashton NJ, Padovani A. Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison. Brain. 2025 Feb 3;148(2):408-415. PubMed. Correction.

Malpetti M, Swann P, Tsvetanov KA, Chouliaras L, Strauss A, Chikaura T, Murley AG, Ashton NJ, Barker P, Jones PS, Fryer TD, Hong YT, Cope TE, Savulich G, Street D, Bevan-Jones WR, Rittman T, Blennow K, Zetterberg H, Aigbirhio FI, O'Brien JT, Rowe JB. Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration. Brain. 2025 Feb 3;148(2):493-505. PubMed.

Kovacs GG, Katsumata Y, Wu X, Aung KZ, Fardo DW, Forrest SL, Alzheimer's Disease Genetics Consortium, Nelson PT. Amyloid-β predominant Alzheimer's disease neuropathologic change. Brain. 2025 Feb 3;148(2):401-407. PubMed.

Husain M. Listening into hippocampal hyperexcitability in Alzheimer's disease. Brain. 2025 Feb 3;148(2):347-348. PubMed.

Bao L, Li X, Tian J, Wang L, Ji Y, Cui Y, Sun W, Zhang J, Xia M, Zhu P, Cui G, Chen H. GGC repeat expansions in NOTCH2NLC cause uN2CpolyG cerebral amyloid angiopathy. Brain. 2025 Feb 3;148(2):467-479. PubMed.

Al-Diwani A, Provine NM, Murchison A, Laban R, Swann OJ, Koychev I, Sheerin F, Da Mesquita S, Heslegrave A, Zetterberg H, Klenerman P, Irani SR. Neurodegenerative fluid biomarkers are enriched in human cervical lymph nodes. Brain. 2025 Feb 3;148(2):394-400. PubMed.

Correction to: Amyloid-β-activated microglia can induce compound proteinopathies. Brain. 2025 Feb 3;148(2):e13. PubMed. Corrected paper.

Wang S, Xu L, Yang W, Wang J, Dove A, Qi X, Xu W. Association of cardiorespiratory fitness with dementia risk across different levels of genetic predisposition: a large community-based longitudinal study. Br J Sports Med. 2025 Feb 3;59(3):150-158. PubMed.

Schaffner SL, Tosefsky KN, Inskter AM, Appel-Cresswell S, Schulze-Hentrich JM. Sex and gender differences in the molecular etiology of Parkinson's disease: considerations for study design and data analysis. Biol Sex Differ. 2025 Feb 3;16(1):7. PubMed.

San Gil R, Walker AK. Unlocking Disease-Modifying Treatments for TDP-43-Mediated Neurodegeneration. Bioessays. 2025 Feb 3;:e202400257. Epub 2025 Feb 3 PubMed.

Panek D, Pasieka A, Jończyk J, Gawlińska M, Zaręba P, Siwek A, Wolak M, Mordyl B, Głuch-Lutwin M, Latacz G, Brazzolotto X, Chantegreil F, Nachon F, Zdarova Karasova J, Pejchal J, Mzik M, Sestak V, Prchal L, Odvarkova J, Soukup O, Korabecny J, Sorf A, Hamsikova M, Zemanova L, Muckova L, Vánova N, Dryja P, Sałat K, Höfner G, Wanner K, Więckowska A, Malawska B. Multifunctional, Fluorene-Based Modulator of Cholinergic and GABAergic Neurotransmission as a Novel Drug Candidate for Palliative Treatment of Alzheimer's Disease. Angew Chem Int Ed Engl. 2025 Feb 3;64(6):e202420510. Epub 2024 Nov 22 PubMed.

Go to another page:

29
30
31
32
33
... 17954

Current Filters

No filters selected

Filter By

Papers of the Week

Current Week (296)
24-30 Jan 2025 (369)
17-23 Jan 2025 (296)
10-16 Jan 2025 (316)

Type ?

Milestone (286)
Alzforum Recommends (3829)

Publication Range

From
1. Month
2. Year
To
1. Month
2. Year

Background
Methods
FAQ

Enter your keywords

LOGIN
HOME
About Us
Newsletter

NEWS
- All News
- Conference Coverage
WEBINARS
- All Webinars
Databases
- AlzAntibodies
- AlzBiomarker
- AlzPedia
- AlzRisk
- Brain Banks
- Genetics
  - AlzGene
  - HEX
  - Mutations
- Protocols
- Research Models
- Therapeutics
PAPERS
PROFESSIONAL RESOURCES
ABOUT AD
MY ALZFORUM

Back to the Top

Terms of Service
How to Cite
Privacy Policy
Site Map
Contact Us